Asian markets followed through on the positive uptick from U.S. markets during the overnight on no real news out of the emergency G7 conference call in this morning’s market update.
In a recent Money Magazine article, Dr. Robert Haugen of Haugen Custom Financial Systems detailed how his research had found that the ‘steadiest’ stocks produced the highest returns over the long term.
U.S. futures are ticking higher suggesting a possible reversal of fortune at the open. The NIKKEI closed down 0.78% while HIS and China closed up 0.26% and 0.01% respectively.
The burgeoning consumer class around the globe has been attracting multinational corporations such as Unilever (UL, quote) and Novatris (NVS, quote), but the stores consumers shop in are just as appealing. Private equity groups and hedge funds have long sought after grocery chains and other retail stores for their dependable cash flow and loyal customer base.
While multinational Big Pharma is looking to emerging markets for growth, drug companies in the emerging world are having a hard time cracking markets in North America and Europe.
After decades of economic progress in China, there is a trend emerging among the growing middle class: spending on medicine.
Teva is a great company in a fantastic global space. Emerging markets need generic drugs. But the chart does not reflect this.